Integra LifeSciences, an integrated medical technology company, has announced the first US implantation of its Integra Titan reverse shoulder system, which is designed for use in the treatment of shoulder replacement surgery.
Integra Titan reverse shoulder system is based on a unique platform stem that simplifies the conversion of a primary total shoulder, or hemi for fracture, to a reverse shoulder, without the need to remove a stem that is well-fixed in the patient's bone.
The reverse shoulder system offers fully interchangeable components that allow all primary, reverse, and fracture humeral bodies to be used with either the press-fit or cemented platform stems.
University of Mississippi Medical Center Orthopaedic Surgery professor and the implanter of the first Integra Titan reverse shoulder system Dr William Geissler noted he was very pleased with the flexibility of the system's platform stem.
"The patient had two unsuccessful attempts at massive cuff repair and was in severe pain, with limited range of motion. During surgery, we found that the patient's cuff tear was not repairable, which, combined with such severe arthritis, made her the perfect patient for reverse shoulder arthroplasty.
Integra LifeSciences corporate vice president extremity reconstruction president Robert Paltridge said the first implantation of company's new Reverse Shoulder System is a great accomplishment, and it is are very pleased with the outcome.
"The system greatly expands our shoulder portfolio and offers surgeons additional options for patients who have exhausted other treatments. We look forward to the continued success and growth in this market," Paltridge added.
